AU2021349249A1 - Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals - Google Patents

Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals Download PDF

Info

Publication number
AU2021349249A1
AU2021349249A1 AU2021349249A AU2021349249A AU2021349249A1 AU 2021349249 A1 AU2021349249 A1 AU 2021349249A1 AU 2021349249 A AU2021349249 A AU 2021349249A AU 2021349249 A AU2021349249 A AU 2021349249A AU 2021349249 A1 AU2021349249 A1 AU 2021349249A1
Authority
AU
Australia
Prior art keywords
compound
substituted
alkyl
unsubstituted
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021349249A
Other languages
English (en)
Inventor
Jason Burch
Stéphane DORICH
Lee Fader
Miguel St-Onge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventus Therapeutics US Inc
Original Assignee
Ventus Therapeutics US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventus Therapeutics US Inc filed Critical Ventus Therapeutics US Inc
Publication of AU2021349249A1 publication Critical patent/AU2021349249A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2021349249A 2020-09-24 2021-09-23 Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals Abandoned AU2021349249A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063082695P 2020-09-24 2020-09-24
US63/082,695 2020-09-24
PCT/US2021/051670 WO2022066851A1 (en) 2020-09-24 2021-09-23 PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

Publications (1)

Publication Number Publication Date
AU2021349249A1 true AU2021349249A1 (en) 2023-04-13

Family

ID=80846865

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021349249A Abandoned AU2021349249A1 (en) 2020-09-24 2021-09-23 Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals

Country Status (7)

Country Link
US (1) US20240018138A1 (https=)
EP (1) EP4216940A4 (https=)
JP (1) JP2023543254A (https=)
CN (1) CN116209442A (https=)
AU (1) AU2021349249A1 (https=)
CA (1) CA3196153A1 (https=)
WO (1) WO2022066851A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022137085A1 (en) 2020-12-22 2022-06-30 Novartis Ag Indole derivatives useful in treating conditions associated with cgas
EP4496796A1 (en) * 2022-03-22 2025-01-29 Ventus Therapeutics U.S., Inc. Hexahydropyrido[4,3-b]indolyl ketone derivatives useful as cgas modulators
AU2023409125A1 (en) * 2022-12-21 2025-06-26 Eli Lilly And Company Azepino[4,5-b]indolone cgas inhibitors
AU2024326748A1 (en) 2023-08-18 2026-04-02 Katholieke Universiteit Leuven 1,3-dihydro-2h-pyrrolo[3,4-c]quinoline derivatives as cgas inhibitors for the treatment of inflammatory and/or autoimmune diseases
CN119490508A (zh) * 2023-08-21 2025-02-21 上海交通大学 一类螺环四氢-γ-咔啉衍生物的制备方法以及应用
WO2025218659A1 (en) * 2024-04-16 2025-10-23 Insilico Medicine Ip Limited Novel compounds as cyclic gmp-amp synthase inhibitor and uses thereof
WO2026026969A1 (zh) * 2024-08-01 2026-02-05 杭州英创医药科技有限公司 作为cGAS抑制剂的化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2424366B1 (en) * 2009-04-29 2016-02-17 Medivation Technologies, Inc. Pyrido [4, 3-b]indoles and methods of use
EP3472162B1 (en) * 2016-06-16 2021-11-17 F. Hoffmann-La Roche AG Heteroaryl estrogen receptor modulators and uses thereof
CN111511729A (zh) * 2017-12-19 2020-08-07 默克专利股份公司 Tlr7/8拮抗剂及其用途
BR112020016008A2 (pt) * 2018-02-05 2020-12-15 The Rockefeller University Composto, método para inibir uma resposta inflamatória em um paciente, método para inibir inflamação em um paciente, método para inibir expressão de interferon ativada por dsdna em um mamífero, método para tratar metástase de câncer em um paciente e formulação farmacêutica
CA3125625A1 (en) * 2019-01-04 2020-07-09 Bellbrook Labs, Llc Inhibitors of cgas activity as therapeutic agents
US12522603B2 (en) * 2019-03-13 2026-01-13 The Rockefeller University Inhibitors of gas for treating autoinflammatory diseases and cancer metastasis

Also Published As

Publication number Publication date
JP2023543254A (ja) 2023-10-13
EP4216940A1 (en) 2023-08-02
CA3196153A1 (en) 2022-03-31
EP4216940A4 (en) 2025-01-01
WO2022066851A1 (en) 2022-03-31
CN116209442A (zh) 2023-06-02
US20240018138A1 (en) 2024-01-18

Similar Documents

Publication Publication Date Title
AU2021349249A1 (en) Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals
CN113286794B (zh) Kras突变蛋白抑制剂
CA3124898C (en) Heterocyclic compound, intermediate, preparation method therefor and application thereof
CN1143080A (zh) 7-二环取代的-3-喹喏酮羧酸衍生物的制备方法
EP3684776A1 (en) Heterocyclyl substituted pyrrolopyridines that are inhibitors of the cdk12 kinase
CN111171049B (zh) 酪氨酸激酶抑制剂及其用途
CN107205972A (zh) 自分泌运动因子的取代的n‑(2‑(氨基)‑2‑氧代乙基)苯甲酰胺抑制剂及它们的制备和在治疗lpa‑依赖的或lpa‑介导的疾病中的用途
TWI762534B (zh) 作為ＰＩ３Ｋδ抑制劑的咪唑並[1,5-A]吡衍生物
CN120659784A (zh) 作为c-Kit激酶抑制剂的化合物和组合物
WO2014151630A2 (en) Compounds and compositions for the treatment of parasitic diseases
JP2020506878A (ja) Ｔｒｅｋ（ｔｗｉｋ関連ｋチャネル）チャネルのアクチベータ
US11858938B2 (en) Imidazo-fused heterocycles and uses thereof
CN114667289B (zh) 杂芳基血浆激肽释放酶抑制剂
CN111704615B (zh) 咪唑并[1,5-A]吡嗪衍生物作为PI3Kδ抑制剂
EP2742044A1 (en) Antibacterial homopiperidinyl substituted 3,4 dihydro 1h [1,8]naphthyridinones
CN121399103A (zh) 一类细胞程序性坏死抑制剂及其制备方法和用途
KR20240121746A (ko) 테트라하이드로피리다진, 이를 포함하는 조성물, 및 이의 용도
WO2023143249A1 (zh) 靶向malt1的蛋白降解化合物
CN115066423B (zh) Pd-l1拮抗剂化合物
CN112778273B (zh) 环酮并吡啶酮类化合物及其制备方法和用途
EP4153571A1 (en) Receptor-interacting protein 1 inhibitors including piperazine heterocyclic amide ureas
US20240132464A1 (en) Heterocyclic compounds as e3 ligase inhibitors
CN112409361B (zh) Tam抑制剂及其用途
HK40093069A (zh) 吡啶并[4，3-b]吲哚衍生物及其作为药物的用途
KR20260025059A (ko) 신규한 치환된 피리딘 유도체 화합물, 이의 제조방법, 및 이를 유효성분으로 포함하는 호흡기 질환의 예방 또는 치료용 약학적 조성물

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period